Related Experiment Videos

Combined hereditary deficiency of the sixth component of complement and factor VIII coagulant activity in a Dutch

Insights

Complement component 6 (C6) deficiency does not impact blood clotting in individuals with hemophilia A. This study found no clinical bleeding issues in patients with combined C6 and factor VIII deficiency.

Area of Science:

  • Hematology
  • Immunology
  • Genetics

Background:

  • Previous studies noted defective blood clotting in C6-deficient rabbits.
  • A patient with combined C6 and factor VIII deficiency prompted this investigation into hemostatic functions.

Observation:

  • Three family members were homozygous for C6 deficiency (C6D), with two also deficient in factor VIII.
  • One member was deficient only in factor VIII.
  • The C6D member without hemophilia A exhibited normal recalcification time and no bleeding symptoms.

Findings:

  • Reconstituting plasma from affected family members with purified human C6 did not alter recalcification times.
  • The study indicates no genetic linkage between the inheritance of C6 and factor VIII.

Implications:

  • C6 deficiency alone does not appear to cause significant hemostatic defects or bleeding disorders.
  • Understanding these deficiencies aids in diagnosing and managing coagulation disorders.

Related Concept Videos